1. Home
  2. KALV vs ODC Comparison

KALV vs ODC Comparison

Compare KALV & ODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$26.76

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Oil-Dri Corporation Of America

ODC

Oil-Dri Corporation Of America

HOLD

Current Price

$76.21

Market Cap

1.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
KALV
ODC
Founded
N/A
1941
Country
United States
United States
Employees
N/A
928
Industry
Biotechnology: Pharmaceutical Preparations
Miscellaneous manufacturing industries
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2014
1994

Fundamental Metrics

Financial Performance
Metric
KALV
ODC
Price
$26.76
$76.21
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$32.60
N/A
AVG Volume (30 Days)
5.0M
33.2K
Earning Date
07-09-2026
06-04-2026
Dividend Yield
N/A
1.13%
EPS Growth
N/A
50.45
EPS
N/A
1.69
Revenue
$50,000,000.00
$485,572,000.00
Revenue This Year
$185.42
N/A
Revenue Next Year
$59.23
N/A
P/E Ratio
N/A
$45.34
Revenue Growth
495.66
10.97
52 Week Low
$9.83
$45.61
52 Week High
$26.85
$79.20

Technical Indicators

Market Signals
Indicator
KALV
ODC
Relative Strength Index (RSI) 74.87 60.99
Support Level $14.45 $70.67
Resistance Level N/A N/A
Average True Range (ATR) 0.07 2.06
MACD -0.06 -0.04
Stochastic Oscillator 54.55 65.54

Price Performance

Historical Comparison
KALV
ODC

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

About ODC Oil-Dri Corporation Of America

Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups, namely the Retail and Wholesale Products Group, which derives maximum revenue, and the Business-to-Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.

Share on Social Networks: